MANNKIND CORP Increase (Decrease) in Contract with Customer, Liability
MANNKIND CORP (MNKD) reported Increase (Decrease) in Contract with Customer, Liability of -$7.37 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-05
- MANNKIND CORP increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$2.49M.
- MANNKIND CORP increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$4.88M.
- MANNKIND CORP increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$3.01M.
- MANNKIND CORP increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $1.89M.
- MANNKIND CORP increase (decrease) in contract with customer, liability for fiscal 2025 was -$8.26M.
- MANNKIND CORP increase (decrease) in contract with customer, liability for fiscal 2024 was -$15.31M, a 138.80% decline from fiscal 2023.
- MANNKIND CORP increase (decrease) in contract with customer, liability for fiscal 2023 was $39.46M, a 107.18% increase from fiscal 2022.
- MANNKIND CORP increase (decrease) in contract with customer, liability for fiscal 2022 was $19.05M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$7.37M 10-Q · filed 2026-08-05 | -$10.38M derived: sum of 3 quarters · filed 2026-08-05 | -$8.48M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$4.88M 10-Q · filed 2026-05-06 | -$7.89M derived: sum of 2 quarters · filed 2026-05-06 | -$6.00M derived: sum of 3 quarters · filed 2026-05-06 | -$8.69M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.12M derived: sum of 2 quarters · filed 2026-02-26 | -$3.81M derived: sum of 3 quarters · filed 2026-08-05 | -$8.26M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$800.00K derived: sum of 2 quarters · filed 2026-08-05 | -$5.25M 10-Q · filed 2025-11-05 | -$13.35M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$7.14M 10-Q · filed 2026-08-05 | -$15.24M derived: sum of 3 quarters · filed 2026-08-05 | -$17.11M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$4.45M 10-Q · filed 2026-05-06 | -$12.55M derived: sum of 2 quarters · filed 2026-05-06 | -$14.42M derived: sum of 3 quarters · filed 2026-05-06 | -$16.23M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$8.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$9.97M derived: sum of 2 quarters · filed 2026-02-26 | -$11.78M derived: sum of 3 quarters · filed 2026-02-26 | -$15.31M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$3.67M derived: sum of 2 quarters · filed 2025-11-05 | -$7.21M 10-Q · filed 2025-11-05 | -$1.47M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$5.34M 10-Q · filed 2025-08-06 | $397.00K derived: sum of 3 quarters · filed 2026-02-26 | $9.80M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$3.54M 10-Q · filed 2025-05-08 | $2.20M derived: sum of 2 quarters · filed 2026-02-26 | $11.61M derived: sum of 3 quarters · filed 2026-02-26 | $27.37M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $5.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.14M derived: sum of 2 quarters · filed 2026-02-26 | $30.90M derived: sum of 3 quarters · filed 2026-02-26 | $39.46M 10-K · filed 2026-02-26 |
| 2023-09-30 | $9.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $25.16M derived: sum of 2 quarters · filed 2024-11-07 | $33.72M 10-Q · filed 2024-11-07 | $39.36M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $15.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $24.32M 10-Q · filed 2024-08-07 | $29.95M derived: sum of 3 quarters · filed 2025-02-26 | $32.31M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $8.56M 10-Q · filed 2024-05-08 | $14.19M derived: sum of 2 quarters · filed 2025-02-26 | $16.55M derived: sum of 3 quarters · filed 2025-02-26 | $20.55M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $5.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $7.99M derived: sum of 2 quarters · filed 2025-02-26 | $11.99M derived: sum of 3 quarters · filed 2025-02-26 | $19.05M 10-K · filed 2025-02-26 |
| 2022-09-30 | $2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $6.36M derived: sum of 2 quarters · filed 2023-11-07 | $13.41M 10-Q · filed 2023-11-07 | $18.21M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $4.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $11.06M 10-Q · filed 2023-08-07 | $15.86M derived: sum of 3 quarters · filed 2024-02-27 | $9.71M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $7.05M 10-Q · filed 2023-05-09 | $11.86M derived: sum of 2 quarters · filed 2024-02-27 | $5.71M derived: sum of 3 quarters · filed 2024-02-27 | -$83.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$1.34M derived: sum of 2 quarters · filed 2024-02-27 | -$7.14M derived: sum of 3 quarters · filed 2024-02-27 | -$14.57M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$6.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$11.94M derived: sum of 2 quarters · filed 2022-11-08 | -$19.37M 10-Q · filed 2022-11-08 | -$15.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$5.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$13.22M 10-Q · filed 2022-08-09 | -$8.85M derived: sum of 3 quarters · filed 2023-02-23 | -$15.33M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$7.43M 10-Q · filed 2022-05-05 | -$3.06M derived: sum of 2 quarters · filed 2023-02-23 | -$9.54M derived: sum of 3 quarters · filed 2023-02-23 | -$5.11M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $4.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$2.11M derived: sum of 2 quarters · filed 2023-02-23 | $2.33M derived: sum of 3 quarters · filed 2023-02-23 | -$5.91M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$6.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$2.05M derived: sum of 2 quarters · filed 2021-11-09 | -$10.28M 10-Q · filed 2021-11-09 | -$4.28M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $4.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$3.80M 10-Q · filed 2021-08-11 | $2.20M derived: sum of 3 quarters · filed 2021-08-11 | -$3.73M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$8.23M 10-Q · filed 2021-05-12 | -$2.23M derived: sum of 2 quarters · filed 2021-05-12 | -$8.16M derived: sum of 3 quarters · filed 2021-05-12 | -$15.64M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $78.00K derived: sum of 2 quarters · filed 2021-02-25 | -$7.40M derived: sum of 3 quarters · filed 2021-02-25 | -$6.72M 10-K · filed 2021-02-25 |
| 2019-09-30 | -$5.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$13.41M derived: sum of 2 quarters · filed 2020-11-04 | -$12.72M 10-Q · filed 2020-11-04 | $22.11M derived: sum of 4 quarters · filed 2020-11-04 |
| 2019-06-30 | -$7.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$6.79M 10-Q · filed 2020-08-05 | $28.04M derived: sum of 3 quarters · filed 2020-08-05 | $37.97M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $686.00K 10-Q · filed 2020-05-06 | $35.52M derived: sum of 2 quarters · filed 2020-05-06 | $45.45M derived: sum of 3 quarters · filed 2020-05-06 | $47.56M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $34.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $44.77M derived: sum of 2 quarters · filed 2020-02-25 | $46.88M derived: sum of 3 quarters · filed 2020-02-25 | $46.81M 10-K · filed 2020-02-25 |
| 2018-09-30 | $9.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $12.05M derived: sum of 2 quarters · filed 2019-11-08 | $11.98M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $2.05M 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | -$63.00K 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | -$381.00K 10-K · filed 2019-02-26 | |||
| 2016-12-31 | $3.42M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |